Moreover, in certain cancers, including kidney renal clear cell carcinoma (KIRC) and lung adenocarcinoma (LUAD), low PCAF expression is associated with poor patient survival (Fig. 5B), indicating that PCAF may be related to tumor resistance to chemotherapy. This evidence concerns the gene KAT2B and lung adenocarcinoma.